Board of directors
Stéphane Sallmard brings with him an exceptional experience in management, paved with numerous accomplishments in innovative product marketing. As CEO and Managing Director of OPTOS Plc. (Edinburgh) in 2001, he orchestrated the fundraising round that brought over $28 million in capital to the company in order to bring their new retinal imaging instrument to market. Under his management, the company’s sales skyrocketed from $1.5 million to $67 million in just 5 years. In 2006, the company went public on the London Stock Exchange raising £50 million in new capital. OPTOS’ growth earned him several honors including the Technology Pioneers Award at the Forum Economique Mondial de Davos. With an engineering degree (Ecole Supérieure d’Electricité Industrielle de Paris) as well a degree in management (Kellogg School of Management, Chicago), Stéphane Sallmard has accumulated 30 years of successful experience in business management, marketing and finance at an array of innovative companies including IBM, Wang, Digital, Nixdorf, Général Electric and Acuson Systems.
Nicolas Chateau has built his career on bringing innovative ophthalmic products to market. He has recently driven Imagine Eyes to commercialize the rtx1 retinal camera, the world’s first and only imaging microscope for the living retina. Since Imagine Eyes’ inception in 2003, Nicolas has piloted its team’s effort to incorporate adaptive optics, a technology derived from astrophysics, into advanced medical instruments. In order to accelerate the technology translation from laboratory to clinic, he has established strong partnerships with leading academic and clinical centers while securing several millions Euros in governmental and European funding. Before cofounding Imagine Eyes, he worked at developing new high-tech optical products for major companies including Coherent, Ocular Sciences and Essilor. Author of 12 patents and dozens of scientific publications in the area of ophthalmic optics, Nicolas received his PhD in physics from the University of Paris in 1993 after graduating from the Institut d’Optique Graduate School in 1988.
Well before he graduated from the prestigious Ecole Supérieure d’Optique, Xavier Levecq had already started inventing new products and filing patents. Recruited while still at university by CILAS-EADS, he developed high-tech optronic systems for « StarWars » military applications based on advanced space optics technologies. In 1996, Xavier co-founded Imagine Optic with Samuel Bucourt. His work in technology development led to the patents and products that propelled their venture into an international success and his wavefront sensors are now recognized worldwide as the reference for optical metrology devices. At Imagine Eyes, Xavier’s boundless creativity and strong team leading skills have lifted company up to the position of a leading pioneer in ophthalmic diagnostic instrumentation.
Soon after his first experience as an engineer at Le Conoscope, Samuel Bucourt became an entrepreneur, co-founding Imagine Optic in association with Xavier Levecq in 1996. In the five short years following the debut of their endeavor, their company had already become an international leader as a provider of optical wavefront sensors. Samuel brings solid expertise in corporate management to Imagine Eyes including sales-force organization, finance, strategic and business development, and growth management.
A graduate of l’Ecole Supérieure de Commerce (Rouen, France), Jamal Labed founded the group SIGHT International in 1987, a data processing training company that is firmly established in France, Portugal, Morocco and Spain. After the sale of the company in 1990, Jamal Labed founded Echo Soft Technologies, a company specialized in developing tools for optimizing SGBD Oracle. He sold the company two years later to Platinum Technology (today Computer Associates). Currently, he dedicates his time to the operational management of EasyVista, which he founded in 1988 with Sylvain Gauthier. The company went public in 2005 and rapidly grew, amassing annual sales of over 15€ million.